Statistics for GlaxoSmithKline PLC (id:3204 GSK)
Valuation metrics
Market cap
55.61B
Enterprise value
65.74B
Trailing P/E (ttm)
21.48
Forward P/E
7.80
PEG ratio
7.80
Price/Sales (ttm)
1.78
Price/Book (mrq)
381.59
Enterprise Value/Revenue
2.10
Enterprise Value/EBITDA
7.10
Overview
Shares outstanding
4.08B
Float
3.95B
Shares short
% Held by insiders
0.02%
% Held by institutions
0.45%
Average volume (10 days)
10.05M
Average volume (90 days)
Price summary
52-Week low
1.28K
52-Week high
1.82K
52-Week change
-5.38%
Beta
0.33
50-Day moving average
1.49K
200-Day moving average
1.60K
Dividends and splits
Forward annual dividend rate
60.00
Forward annual dividend yield
0.04
Trailing annual dividend rate
0.61%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
4.86
Payout ratio
0.99
Dividend date
Ex-dividend date
November 14th, 2024
Last split factor
2:1
Last split date
July 19th, 2022
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
8.02%
Operating margin
8.32%
Operational effectiveness
Return on assets
7.24%
Return on equity
21.85%
Income statement
Revenue (ttm)
7.69
Revenue per share (ttm)
7.69
Quarterly revenue growth (yoy)
Gross profit (ttm)
21.76B
EBITDA
7.25B
Net income to common (ttm)
2.51B
Diluted EPS (ttm)
0.61
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
3.21B
Total cash per share (mrq)
0.79
Total debt (mrq)
16.06B
Total Debt/Equity (mrq)
119.37
Current ratio (mrq)
80.60%
Book value per share (mrq)
3.43
Cash flow
Cash flow statement
7.42B
Levered free cash flow (LFCF)
6.04B